embecta to Participate in Investor Events
Embecta Corp. (EMBC), a global diabetes care company, has announced its participation in two upcoming investor events.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Embecta Corp. (EMBC), a global diabetes care company, has announced its participation in two upcoming investor events. The company will attend the 2024 Wells Fargo Healthcare Conference on September 4, hosting one-on-one investor meetings at the Encore Boston Harbor Hotel. Additionally, embecta will participate in the 2024 Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, where management will host a fireside session at 2:35 p.m. ET at the Marriott Marquis in New York.
These events provide opportunities for investors to engage with embecta's management and gain insights into the company's operations and strategy. Audio webcasts of the presentations will be available on embecta's investor relations website under the 'News & Events' section, allowing wider access to the company's updates and discussions.
Details
News Market Reaction – EMBC
The recorded move for EMBC in the trading session of this news was +6.14%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that management will participate in the following investor events:
2024 Wells Fargo Healthcare Conference
| • | Management will host one-on-one investor meetings on Wednesday, September 4, 2024, at the Encore Boston Harbor Hotel in Boston. |
2024 Morgan Stanley 22nd Annual Global Healthcare Conference
| • | Management will host a fireside session on Thursday, September 5, 2024, at 2:35 p.m. Eastern Time (ET) at the Marriott Marquis in New York. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at https://investors.embecta.com. |
About embecta
embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships, and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, Instagram and Twitter.
Contacts:
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.